5 results
The main objective of this study is to assess whether in-hospital administration of empagliflozin results in improvement in HF-related outcomes in patients hospitalised for acute heart failure (de novo or decompensated chronic HF) and after initial…
Medtronic, Inc. is sponsoring the SMART Trial, a prospective, multi-center, international, randomized controlled, post-market trial. The purpose of this trial is to generate clinical evidence on valve safety and performance of SE versus BE TAVR in…
To investigate the potential of preoperative initiation (7 days) and perioperative continuation (until day 2 after surgery) of empagliflozin 10 mg daily to reduce the acute kidney injury marker neutrophil gelatinase-associated lipocalin (NGAL) on…
To examine the effects of mono- and combination therapy with linagliptin and empagliflozine on renal hemodynamics
The aim of this study is to determine NET availability in patients with neurodegenerative diseases to characterize NA system degeneration in people with Alzheimer's disease, Parkinson's disease (with and without dementia) and with…